ArticleScientific reports2024

Targeting human progesterone receptor (PR), through pharmacophore-based screening and molecular simulation revealed potent inhibitors against breast cancer.

Muhammad Shahab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.